| Primary |
| Diabetes Mellitus |
50.0% |
| Type 2 Diabetes Mellitus |
50.0% |
|
| Pancreatitis |
64.3% |
| Constipation |
7.1% |
| Pancreatitis Acute |
7.1% |
| Pancreatitis Chronic |
7.1% |
| Pruritus |
7.1% |
| Vomiting |
7.1% |
|
| Secondary |
| Product Used For Unknown Indication |
46.9% |
| Diabetes Mellitus |
14.3% |
| Type 2 Diabetes Mellitus |
12.2% |
| Dyslipidaemia |
6.1% |
| Eczema |
4.1% |
| Pneumonia |
4.1% |
| Gastritis |
2.0% |
| Gastritis Prophylaxis |
2.0% |
| Hypercholesterolaemia |
2.0% |
| Hypertension |
2.0% |
| Myelodysplastic Syndrome |
2.0% |
| Pulmonary Mycosis |
2.0% |
|
| Pancreatitis Acute |
18.2% |
| Dizziness |
9.1% |
| Leukocytoclastic Vasculitis |
9.1% |
| Pancreatitis |
9.1% |
| Pruritus |
9.1% |
| Splenomegaly |
9.1% |
| Tremor |
9.1% |
| Ventricular Tachycardia |
9.1% |
| Vision Blurred |
9.1% |
| Vomiting |
9.1% |
|
| Concomitant |
| Type 2 Diabetes Mellitus |
40.0% |
| Product Used For Unknown Indication |
11.2% |
| Plasma Cell Myeloma |
7.2% |
| Diabetes Mellitus |
5.6% |
| Chronic Myeloid Leukaemia |
4.8% |
| Depression |
4.0% |
| Hepatitis C |
4.0% |
| Osteoporosis |
3.2% |
| Multiple Myeloma |
2.4% |
| Prostate Cancer Metastatic |
2.4% |
| Skin Cancer |
2.4% |
| Fabry's Disease |
1.6% |
| Hypertension |
1.6% |
| Multiple Sclerosis |
1.6% |
| Myelodysplastic Syndrome |
1.6% |
| Nephrogenic Anaemia |
1.6% |
| Radioactive Iodine Therapy |
1.6% |
| Type Ii Diabetes Mellitus |
1.6% |
| Type 2 Diabetes Mellitus |
0.8% |
| Attention Deficit/hyperactivity Disorder |
0.8% |
|
| Bladder Cancer |
24.0% |
| Pancreatitis |
9.3% |
| Renal Failure |
9.3% |
| Somnolence |
5.3% |
| Blood Glucose Increased |
4.0% |
| Constipation |
4.0% |
| Nausea |
4.0% |
| Urinary Tract Infection |
4.0% |
| Vision Blurred |
4.0% |
| Vomiting |
4.0% |
| Weight Decreased |
4.0% |
| Bladder Cancer Recurrent |
2.7% |
| Dyspnoea |
2.7% |
| Full Blood Count Decreased |
2.7% |
| Hypertension |
2.7% |
| Off Label Use |
2.7% |
| Pain In Jaw |
2.7% |
| Peripheral Arterial Occlusive Disease |
2.7% |
| Platelet Count Decreased |
2.7% |
| Product Quality Issue |
2.7% |
|
